Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma ; volume:18 ; number:1 ; day:26 ; month:10 ; year:2018 ; pages:1-8 ; date:12.2018
BMC cancer ; 18, Heft 1 (26.10.2018), 1-8, 12.2018
- Urheber
-
Park, Jongmoo
Jung, Jinhong
Kim, Daegeun
Jung, In-Hye
Park, Jin-hong
Kim, Jong Hoon
Lee, Sang-wook
Yoon, Sang Min
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4953-x
- URN
-
urn:nbn:de:101:1-2018121622592180912882
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Park, Jongmoo
- Jung, Jinhong
- Kim, Daegeun
- Jung, In-Hye
- Park, Jin-hong
- Kim, Jong Hoon
- Lee, Sang-wook
- Yoon, Sang Min
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review